本文選題：項(xiàng)目管理 + 新藥研發(fā)��； 參考：《電子科技大學(xué)》2013年碩士論文

【摘要】：現(xiàn)代生物醫(yī)藥產(chǎn)業(yè)的快速發(fā)展對企業(yè)的資金、管理等提出了更高的要求。隨著各大藥企研發(fā)力度的不斷加大，與研發(fā)相配套的項(xiàng)目管理水平也應(yīng)不斷提高，這樣才能在能保證藥企在做研發(fā)項(xiàng)目時，提高效率和成功率，并相應(yīng)縮短研發(fā)周期，降低研發(fā)風(fēng)險(xiǎn)。 本篇論文即通過分析CK所新藥研發(fā)項(xiàng)目管理中存在的項(xiàng)目組織管理結(jié)構(gòu)問題、風(fēng)險(xiǎn)管理問題，以及進(jìn)度管理問題，提出在CK所的研發(fā)項(xiàng)目中引入科學(xué)項(xiàng)目管理的方法以改進(jìn)和解決以上問題。論文的主要內(nèi)容為：為CK所構(gòu)建了更適合項(xiàng)目管理的平衡矩陣式項(xiàng)目組織管理模式，通過在項(xiàng)目團(tuán)隊(duì)中加入項(xiàng)目助理，改進(jìn)了項(xiàng)目的溝通問題和進(jìn)度管理問題，通過加入情報(bào)團(tuán)隊(duì)，加強(qiáng)了立項(xiàng)調(diào)研，降低了項(xiàng)目的立項(xiàng)風(fēng)險(xiǎn)；本文從技術(shù)風(fēng)險(xiǎn)、費(fèi)用風(fēng)險(xiǎn)，管理風(fēng)險(xiǎn)、政策風(fēng)險(xiǎn)、知識產(chǎn)權(quán)風(fēng)險(xiǎn)、生產(chǎn)風(fēng)險(xiǎn)、市場風(fēng)險(xiǎn)等7個方面分析了本所新藥研發(fā)項(xiàng)目可能會遇到的風(fēng)險(xiǎn)因素，對每個風(fēng)險(xiǎn)進(jìn)行詳細(xì)闡述，并提出相應(yīng)的應(yīng)對策略，以便于在項(xiàng)目研發(fā)過程中降低風(fēng)險(xiǎn)，并為CK所以后系統(tǒng)化項(xiàng)目風(fēng)險(xiǎn)管理的開展打下基礎(chǔ)；本文還將工作分解結(jié)構(gòu)（WBS）、關(guān)鍵路徑法、項(xiàng)目甘特圖、項(xiàng)目網(wǎng)絡(luò)圖（AON圖）等工具和技術(shù)應(yīng)用到本所的新藥研發(fā)項(xiàng)目中，研究了在CK所實(shí)施項(xiàng)目進(jìn)度管理的必要性和可能性，探討了本所新藥研發(fā)項(xiàng)目如何在有限的時間和資源限制下，提高工作效率、降低費(fèi)用、縮短單個項(xiàng)目的研發(fā)周期并成功完成新藥申報(bào)，最后本文還采用回顧性研究的方法，結(jié)合CK所一個研發(fā)項(xiàng)目的成功案例，將科學(xué)項(xiàng)目進(jìn)度管理的方法應(yīng)用到該項(xiàng)目中。 總之，本文通過項(xiàng)目管理體系在新藥研發(fā)項(xiàng)目管理上的應(yīng)用，使本所新藥研發(fā)項(xiàng)目的管理水平得以提升，，提高本所研發(fā)的效率，并降低了風(fēng)險(xiǎn)，使CK所在醫(yī)藥研發(fā)領(lǐng)域更具競爭力。
[Abstract]:The rapid development of modern biopharmaceutical industry has put forward higher requirements to the capital and management of enterprises. As the R & D efforts of the major pharmaceutical enterprises continue to increase, the level of project management associated with R & D should also be continuously improved, so that the efficiency and success rate can be improved and the R & D cycle can be shortened accordingly in order to ensure that the pharmaceutical enterprises are doing R & D projects. Reduce R & D risk. This paper analyzes the problems of project organization and management, risk management and schedule management in the management of new drug research and development project in CK Institute. In order to improve and solve the above problems, this paper puts forward the method of introducing scientific project management into the R & D project of CK Institute. The main contents of this paper are as follows: a balanced matrix project management model is constructed for CK, which is more suitable for project management. By adding a project assistant to the project team, the communication and schedule management problems of the project are improved. By joining the intelligence team, the research on project establishment has been strengthened, and the project risk has been reduced. In this paper, the risks of technology, cost, management, policy, intellectual property, production, etc. This paper analyzes the risk factors that may be encountered in the new drug R & D project of the Institute from seven aspects such as market risk, expounds each risk in detail, and puts forward corresponding countermeasures in order to reduce the risk in the process of project research and development. And lay the foundation for the risk management of post-systematization project of CK, and apply the tools and technologies such as work breakdown structure, critical path method, project Gantt diagram, project network diagram to the new drug R & D project of our institute. This paper studies the necessity and possibility of the project schedule management in CK, and discusses how to improve the working efficiency and reduce the cost of the new drug R & D project in the institute under the limited time and resources. The research cycle of a single project is shortened and the new drug application is successfully completed. Finally, the method of scientific project schedule management is applied to the project by using the method of retrospective research and combining with the successful case of a R & D project in CK. In a word, through the application of the project management system in the project management of new drug research and development, the management level of the new drug research and development project of the institute can be improved, the efficiency of the research and development of the institute can be improved, and the risk can be reduced. To make CK in the field of pharmaceutical research and development more competitive.
【學(xué)位授予單位】：電子科技大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2013
【分類號】：F426.72;R954

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 張波;沈洪明;張國盛;;新藥研發(fā)項(xiàng)目的風(fēng)險(xiǎn)識別[J];商場現(xiàn)代化;2006年30期

2 吳紅雁;馮國忠;;新藥研發(fā)過程中的風(fēng)險(xiǎn)管理[J];上海醫(yī)藥;2007年12期

3 劉蘭茹;劉佳明;;新藥研發(fā)中的風(fēng)險(xiǎn)控制[J];中國衛(wèi)生經(jīng)濟(jì);2007年08期

4 周碩;徐琳;芮國忠;;新藥研發(fā)項(xiàng)目風(fēng)險(xiǎn)評價(jià)指標(biāo)體系研究進(jìn)展[J];中國醫(yī)藥技術(shù)經(jīng)濟(jì)與管理;2008年04期

5 邢花;李野;傅書勇;;新藥研發(fā)項(xiàng)目的范圍管理[J];中國醫(yī)藥技術(shù)經(jīng)濟(jì)與管理;2008年09期

6 王朋;徐懷伏;;新藥上市前風(fēng)險(xiǎn)分析及對策[J];中國醫(yī)藥技術(shù)經(jīng)濟(jì)與管理;2008年11期

7 程艷,馬愛霞;我國制藥企業(yè)新藥研發(fā)的風(fēng)險(xiǎn)與對策[J];藥學(xué)進(jìn)展;2004年02期

8 黎敏,邢花;新藥研發(fā)項(xiàng)目的時間管理[J];中國藥業(yè);2004年06期

9 于海,黃泰康,吳春福;新藥研發(fā)過程中的項(xiàng)目管理[J];中國藥業(yè);2004年12期

10 邢花;李野;;新藥研發(fā)項(xiàng)目管理知識領(lǐng)域的拓展[J];中國藥業(yè);2008年12期

相關(guān)博士學(xué)位論文 前1條

1 邢花;新藥研發(fā)項(xiàng)目管理知識體系構(gòu)建[D];沈陽藥科大學(xué);2009年

相關(guān)碩士學(xué)位論文 前4條

1 張波;新藥研發(fā)項(xiàng)目的風(fēng)險(xiǎn)管理研究[D];江南大學(xué);2007年

2 周云久;淫羊藿注射液臨床前研發(fā)項(xiàng)目管理研究[D];哈爾濱工程大學(xué);2007年

3 黃糧美;基于XPM理論的藥品開發(fā)的研究[D];上海交通大學(xué);2008年

4 張彩霞;新藥研發(fā)項(xiàng)目管理優(yōu)化研究[D];天津大學(xué);2009年

本文編號：1894496